U.S., March 18 -- ClinicalTrials.gov registry received information related to the study (NCT06880289) titled 'Chemo-Radiotherapy Boost Treatment Guided by Perfusion MRI on Hypoxic Zones in Head and Neck Cancer' on March 11.
Brief Summary: To assess and localize hypoxic tumor subregions both at baseline and during the second week of radiotherapy. And to hypothesize that an intensified IMRT regimen may ensure higher local response rates compared to the standard IMRT approach.
Study Start Date: Sept. 16, 2020
Study Type: INTERVENTIONAL
Condition:
Squamous Cell Tumors of the Head and Neck
Intervention:
DRUG: Cisplatin IV on days 1, 22, 43, at a dose of 100 mg/m2
Chemoradiotherapy will be performed from day 1 to day 49 regardless of the ...